Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short term Debt (2017 - 2024)

Historic Short term Debt for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2024 value amounting to $6.0 million.

  • Organogenesis Holdings' Short term Debt rose 877.26% to $6.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.0 million, marking a year-over-year increase of 877.26%. This contributed to the annual value of $5.5 million for FY2023, which is 2089.03% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Short term Debt of $6.0 million as of Q3 2024, which was up 877.26% from $5.8 million recorded in Q2 2024.
  • Over the past 5 years, Organogenesis Holdings' Short term Debt peaked at $22.5 million during Q2 2021, and registered a low of $1.7 million during Q1 2020.
  • In the last 5 years, Organogenesis Holdings' Short term Debt had a median value of $5.5 million in 2023 and averaged $7.1 million.
  • The largest annual percentage gain for Organogenesis Holdings' Short term Debt in the last 5 years was 91229.75% (2021), contrasted with its biggest fall of 8406.34% (2021).
  • Over the past 5 years, Organogenesis Holdings' Short term Debt (Quarter) stood at $16.7 million in 2020, then plummeted by 84.06% to $2.7 million in 2021, then surged by 70.86% to $4.5 million in 2022, then grew by 20.89% to $5.5 million in 2023, then grew by 8.71% to $6.0 million in 2024.
  • Its last three reported values are $6.0 million in Q3 2024, $5.8 million for Q2 2024, and $5.5 million during Q1 2024.